Literature DB >> 30488443

Identification of dysregulated miRNAs in triple negative breast cancer: A meta-analysis approach.

Leimarembi Devi Naorem1, Mathavan Muthaiyan1, Amouda Venkatesan1.   

Abstract

Triple negative breast cancer (TNBC) is an aggressive subtype of breast cancer with poor clinical outcomes and lack of approved targeted therapy. Dysregulated microRNAs (miRNAs) have been considered a promising biomarker, which plays an important role in the tumorigenesis of human cancer. Due to the increase in miRNA profiling datasets of TNBC, a proper analysis is required for studying. Therefore, this study used meta-analysis to amalgamate ten miRNA profiling studies of TNBC. By the robust rank aggregation method, metasignatures of six miRNAs (4 upregulated: hsa-miR-135b-5p, hsa-miR-18a-5p, hsa-miR-9-5p and hsa-miR-522-3p; 2 downregulated: hsa-miR-190b and hsa-miR-449a) were obtained. The gene ontology analysis revealed that target genes regulated by miRNAs were associated with processes like the regulation of transcription, DNA dependent, and signal transduction. Also, it is noted from the pathway analysis that signaling and cancer pathways were associated with the progression of TNBC. A Naïve Bayes-based classifier built with miRNA signatures discriminates TNBC and non-TNBC samples in test data set with high diagnostic sensitivity and specificity. From the analysis carried out by the study, it is suggested that the identified miRNAs are of great importance in improving the diagnostics and therapeutics for TNBC.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  Naïve Bayes; gene ontology (GO); miRNA; robust rank aggregation (RRA); triple negative breast cancer (TNBC)

Mesh:

Substances:

Year:  2018        PMID: 30488443     DOI: 10.1002/jcp.27839

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  18 in total

1.  Single-Molecule Sensor for High-Confidence Detection of miRNA.

Authors:  Kalani M Wijesinghe; Mazhar A Kanak; J Chuck Harrell; Soma Dhakal
Journal:  ACS Sens       Date:  2022-03-21       Impact factor: 7.711

2.  MiR-27a-3p Targeting GSK3β Promotes Triple-Negative Breast Cancer Proliferation and Migration Through Wnt/β-Catenin Pathway.

Authors:  Ruizhen Wu; Bingqing Zhao; Xunxin Ren; Shiheng Wu; Mingzao Liu; Zipeng Wang; Wei Liu
Journal:  Cancer Manag Res       Date:  2020-07-24       Impact factor: 3.989

Review 3.  Triple-negative breast cancer: A run-through of features, classification and current therapies.

Authors:  Meghana Manjunath; Bibha Choudhary
Journal:  Oncol Lett       Date:  2021-05-05       Impact factor: 2.967

4.  MicroRNA-9-5p Facilitates Lung Adenocarcinoma Cell Malignant Progression via Targeting STARD13.

Authors:  Yunping Lu; Weifen Zheng; Xiao Rao; Yinggan Du; Jianbo Xue
Journal:  Biochem Genet       Date:  2022-02-04       Impact factor: 1.890

5.  Long non-coding RNA linc00921 suppresses tumorigenesis and epithelial-to-mesenchymal transition of triple-negative breast cancer via targeting miR-9-5p/LZTS2 axis.

Authors:  Jie Zhang; Lina Zhang; Jianlong Wang; Jing Zhao; Xuelian Zhao; Chunli Zhang; Peng Han; Cuizhi Geng
Journal:  Hum Cell       Date:  2022-02-18       Impact factor: 4.374

6.  miR-148b-3p, miR-190b, and miR-429 Regulate Cell Progression and Act as Potential Biomarkers for Breast Cancer.

Authors:  Wenzhu Dai; Jixiang He; Ling Zheng; Mingyu Bi; Fei Hu; Minju Chen; Heng Niu; Jingyu Yang; Ying Luo; Wenru Tang; Miaomiao Sheng
Journal:  J Breast Cancer       Date:  2019-04-19       Impact factor: 3.588

7.  Prolonged Time to Adjuvant Chemotherapy Initiation Was Associated with Worse Disease Outcome in Triple Negative Breast Cancer Patients.

Authors:  Lifen Cai; Yiwei Tong; Xiaoping Zhu; Kunwei Shen; Juanying Zhu; Xiaosong Chen
Journal:  Sci Rep       Date:  2020-04-27       Impact factor: 4.379

Review 8.  MicroRNAs Involved in Carcinogenesis, Prognosis, Therapeutic Resistance and Applications in Human Triple-Negative Breast Cancer.

Authors:  Lei Ding; Huan Gu; Xianhui Xiong; Hongshun Ao; Jiaqi Cao; Wen Lin; Min Yu; Jie Lin; Qinghua Cui
Journal:  Cells       Date:  2019-11-22       Impact factor: 6.600

9.  MicroRNA-497-5p Induces Cell Cycle Arrest Of Cervical Cancer Cells In S Phase By Targeting CBX4.

Authors:  Yani Chen; Juan Du; Yu Wang; Haiyan Shi; Qiuyu Jiang; Yangfeng Wang; Huahua Zhang; Yameng Wei; Wanjuan Xue; Zhiying Pu; Yi Gao; Dan Li; Yun Feng; Jing Yan; Jing Zhang
Journal:  Onco Targets Ther       Date:  2019-12-02       Impact factor: 4.147

10.  Circulating non‑coding RNA‑biomarker potential in neoadjuvant chemotherapy of triple negative breast cancer?

Authors:  Andrea Ritter; Marc Hirschfeld; Kai Berner; Gerta Rücker; Markus Jäger; Daniela Weiss; Markus Medl; Claudia Nöthling; Sandra Gassner; Jasmin Asberger; Thalia Erbes
Journal:  Int J Oncol       Date:  2019-11-25       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.